These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 35643089

  • 1. Immunoglobulin-free strategy to prevent HBV mother-to-child transmission in Cambodia (TA-PROHM): a single-arm, multicentre, phase 4 trial.
    Segeral O, Dim B, Durier C, Nhoueng S, Chhim K, Sovann S, Yom S, Vong C, Yin S, Ros B, Ky V, Pech S, Nem B, Hout K, Guillebaud J, Ear E, Caroupaye-Caroupin L, Rekacewicz C, Fernandez L, Laurent D, Yay C, Kim R, Meyer L, Chhun S, Laurence Borand for the ANRS-MIE TA PROHM Study Group.
    Lancet Infect Dis; 2022 Aug; 22(8):1181-1190. PubMed ID: 35643089
    [Abstract] [Full Text] [Related]

  • 2. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G, Ngo-Giang-Huong N, Cressey TR, Hua L, Harrison L, Tierney C, Salvadori N, Decker L, Traisathit P, Sirirungsi W, Khamduang W, Bowonwatanuwong C, Puthanakit T, Siberry GK, Watts DH, Murphy TV, Achalapong J, Hongsiriwon S, Klinbuayaem V, Thongsawat S, Chung RT, Pol S, Chotivanich N.
    BMC Infect Dis; 2016 Aug 09; 16():393. PubMed ID: 27506549
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
    Eke AC, Eleje GU, Eke UA, Xia Y, Liu J.
    Cochrane Database Syst Rev; 2017 Feb 11; 2(2):CD008545. PubMed ID: 28188612
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria.
    Ndububa D, Kuti O, Awowole I, Adekanle O, Ijarotimi O, Makinde O, Adeyemi A, Anyabolu C, Ijadunola M.
    BMJ Open; 2022 Nov 08; 12(11):e063482. PubMed ID: 36351715
    [Abstract] [Full Text] [Related]

  • 7. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G, Ngo-Giang-Huong N, Harrison L, Decker L, Khamduang W, Tierney C, Salvadori N, Cressey TR, Sirirungsi W, Achalapong J, Yuthavisuthi P, Kanjanavikai P, Na Ayudhaya OP, Siriwachirachai T, Prommas S, Sabsanong P, Limtrakul A, Varadisai S, Putiyanun C, Suriyachai P, Liampongsabuddhi P, Sangsawang S, Matanasarawut W, Buranabanjasatean S, Puernngooluerm P, Bowonwatanuwong C, Puthanakit T, Klinbuayaem V, Thongsawat S, Thanprasertsuk S, Siberry GK, Watts DH, Chakhtoura N, Murphy TV, Nelson NP, Chung RT, Pol S, Chotivanich N.
    N Engl J Med; 2018 Mar 08; 378(10):911-923. PubMed ID: 29514030
    [Abstract] [Full Text] [Related]

  • 8. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial.
    Buti M, Gane E, Seto WK, Chan HL, Chuang WL, Stepanova T, Hui AJ, Lim YS, Mehta R, Janssen HL, Acharya SK, Flaherty JF, Massetto B, Cathcart AL, Kim K, Gaggar A, Subramanian GM, McHutchison JG, Pan CQ, Brunetto M, Izumi N, Marcellin P, GS-US-320-0108 Investigators.
    Lancet Gastroenterol Hepatol; 2016 Nov 08; 1(3):196-206. PubMed ID: 28404092
    [Abstract] [Full Text] [Related]

  • 9. Tenofovir alafenamide or tenofovir disoproxil fumarate in pregnancy to prevent HBV transmission: Maternal ALT trajectory and infant outcomes.
    Chen HL, Lee CN, Chang CH, Lai MW, Tsai MC, Mu SC, Liu CJ, Shih JC, Wen WH, Hu RT, Huang CP, Hu KC, Chen CP, Lee CL, Chien RN, Chang KC, Hsu HY, Lee CC, Ni YH, Chang MH.
    Liver Int; 2024 Jun 08; 44(6):1422-1434. PubMed ID: 38456620
    [Abstract] [Full Text] [Related]

  • 10. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
    Zhang BF, Cheng ML, Zhang Q, Zhao XK, Yu L, Yang J, Deng KS, Zhang LS, Wang J, Hu YX.
    Zhonghua Gan Zang Bing Za Zhi; 2018 Dec 20; 26(12):945-950. PubMed ID: 30669789
    [Abstract] [Full Text] [Related]

  • 11. Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load.
    Pan CQ, Duan Z, Dai E, Zhang S, Han G, Wang Y, Zhang H, Zou H, Zhu B, Zhao W, Jiang H, China Study Group for the Mother-to-Child Transmission of Hepatitis B.
    N Engl J Med; 2016 Jun 16; 374(24):2324-34. PubMed ID: 27305192
    [Abstract] [Full Text] [Related]

  • 12. Real-world study of tenofovir disoproxil fumarate to prevent hepatitis B transmission in mothers with high viral load.
    Wang M, Bian Q, Zhu Y, Pang Q, Chang L, Li R, Tiongson BC, Zhang H, Pan CQ.
    Aliment Pharmacol Ther; 2019 Jan 16; 49(2):211-217. PubMed ID: 30506691
    [Abstract] [Full Text] [Related]

  • 13. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H, Aladag M.
    Eur Rev Med Pharmacol Sci; 2023 Mar 16; 27(5):2091-2098. PubMed ID: 36930508
    [Abstract] [Full Text] [Related]

  • 14. Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis.
    Bierhoff M, Angkurawaranon C, Rijken MJ, Sriprawa K, Kobphan P, Nosten FN, van Vugt M, McGready R, Devine A.
    BMC Pregnancy Childbirth; 2021 Feb 22; 21(1):157. PubMed ID: 33618698
    [Abstract] [Full Text] [Related]

  • 15. Tenofovir for prevention of mother to child transmission of hepatitis B in migrant women in a resource-limited setting on the Thailand-Myanmar border: a commentary on challenges of implementation.
    Bierhoff M, Rijken MJ, Yotyingaphiram W, Pimanpanarak M, van Vugt M, Angkurawaranon C, Nosten F, Ehrhardt S, Thio CL, McGready R.
    Int J Equity Health; 2020 Sep 10; 19(1):156. PubMed ID: 32912268
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of antiviral prophylaxis during pregnancy to prevent mother-to-child transmission of hepatitis B virus: a systematic review and meta-analysis.
    Funk AL, Lu Y, Yoshida K, Zhao T, Boucheron P, van Holten J, Chou R, Bulterys M, Shimakawa Y.
    Lancet Infect Dis; 2021 Jan 10; 21(1):70-84. PubMed ID: 32805200
    [Abstract] [Full Text] [Related]

  • 17. Association of vitamin D and polymorphisms of its receptor with antiviral therapy in pregnant women with hepatitis B.
    Wang R, Zhu X, Zhang X, Liu H, Ji YL, Chen YH.
    World J Gastroenterol; 2023 May 21; 29(19):3003-3012. PubMed ID: 37274802
    [Abstract] [Full Text] [Related]

  • 18. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    Ugwu EO, Eleje GU, Ugwu AO, Nwagha UI, Ikechebelu JI, Umeh UA, Okafor HU.
    Cochrane Database Syst Rev; 2023 Jun 12; 6(6):CD013653. PubMed ID: 37306558
    [Abstract] [Full Text] [Related]

  • 19. Effects of hepatitis B immunization on prevention of mother-to-infant transmission of hepatitis B virus and on the immune response of infants towards hepatitis B vaccine.
    Zhang L, Gui XE, Teter C, Zhong H, Pang Z, Ding L, Li F, Zhou Y, Zhang L.
    Vaccine; 2014 Oct 21; 32(46):6091-7. PubMed ID: 25240752
    [Abstract] [Full Text] [Related]

  • 20. Kinetics of hepatitis B surface antigen in pregnant women with and without tenofovir disoproxil fumarate.
    Chang HL, Wen WH, Lee CN, Chiu YE, Liu CJ, Chang MH, Lin LH, Chen HL.
    J Viral Hepat; 2022 Feb 21; 29(2):107-114. PubMed ID: 34724288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.